NPI: 1457366189 · KENDALLVILLE, IN 46755 · Institutional Pharmacy · NPI assigned 07/30/2006
Authorized official RISSER, STANTON controls 20+ related entities in our dataset. Read more
| Authorized Official | RISSER, STANTON (ACFO) |
| Parent Organization | COMMUNITY HOSPITAL OF NOBLE COUNTY, INC. |
| NPI Enumeration Date | 07/30/2006 |
Other providers sharing the same authorized official: RISSER, STANTON
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 23,768 | $588K |
| 2019 | 16,750 | $767K |
| 2020 | 15,516 | $1.03M |
| 2021 | 25,769 | $1.78M |
| 2022 | 30,068 | $1.89M |
| 2023 | 20,648 | $1.50M |
| 2024 | 13,744 | $917K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 22,397 | 19,645 | $3.88M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,142 | 8,424 | $1.42M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,780 | 695 | $890K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,840 | 4,794 | $349K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,110 | 1,916 | $348K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,320 | 1,090 | $277K |
| 71045 | Radiologic examination, chest; single view | 1,908 | 1,546 | $243K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,971 | 1,709 | $138K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 336 | 281 | $116K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3,692 | 3,121 | $96K |
| 71046 | Radiologic examination, chest; 2 views | 718 | 632 | $74K |
| 80048 | Basic metabolic panel (calcium, ionized) | 16,800 | 13,551 | $71K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,397 | 13,479 | $67K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1,042 | 583 | $61K |
| 36415 | Collection of venous blood by venipuncture | 17,914 | 14,630 | $32K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 494 | 414 | $31K |
| 80050 | General health panel | 172 | 147 | $23K |
| 80076 | 5,428 | 4,503 | $23K | |
| 80074 | 534 | 488 | $23K | |
| 84484 | 3,275 | 2,500 | $21K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 307 | 259 | $19K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,102 | 854 | $18K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,646 | 1,512 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | 206 | 152 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 485 | 405 | $16K |
| 80061 | Lipid panel | 1,598 | 1,465 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,997 | 1,802 | $11K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 403 | 362 | $11K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 80 | 75 | $10K |
| 99217 | 22 | 15 | $10K | |
| 83690 | 3,396 | 2,818 | $10K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26 | 14 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 580 | 532 | $9K |
| 80053 | Comprehensive metabolic panel | 1,051 | 966 | $8K |
| 99219 | 22 | 17 | $8K | |
| 81001 | 4,549 | 3,849 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 145 | 130 | $6K |
| 99238 | Hospital discharge day management, 30 minutes or less | 14 | 14 | $6K |
| 96361 | Intravenous infusion, hydration; each additional hour | 225 | 196 | $6K |
| 83735 | 1,460 | 1,165 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 456 | 425 | $5K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 124 | 119 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 121 | 112 | $5K |
| 76801 | 25 | 24 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 355 | 276 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 71 | 65 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 930 | 784 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 174 | 163 | $4K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 30 | 28 | $3K |
| 87634 | 61 | 50 | $3K | |
| 81025 | 500 | 440 | $3K | |
| 87522 | Neg quan hep c or qual rna | 87 | 83 | $3K |
| 82607 | 453 | 422 | $3K | |
| 85027 | 777 | 627 | $2K | |
| 86481 | 30 | 29 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 301 | 257 | $2K |
| 80055 | 49 | 44 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 118 | 104 | $1K |
| 73630 | 14 | 14 | $697.95 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 251 | 222 | $590.46 |
| 86803 | 51 | 45 | $514.58 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 14 | 12 | $453.60 |
| 80355 | 12 | 12 | $420.00 | |
| 84460 | 210 | 199 | $377.05 | |
| 84450 | 211 | 200 | $374.75 | |
| 84439 | 120 | 108 | $372.56 | |
| 81003 | 273 | 222 | $363.08 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 16 | 13 | $272.76 |
| A0429 | Ambulance service, basic life support, emergency transport (bls-emergency) | 964 | 757 | $270.00 |
| 85379 | 31 | 24 | $226.04 | |
| 82728 | 43 | 40 | $199.23 | |
| 82962 | 85 | 73 | $154.73 | |
| 83550 | 43 | 40 | $127.87 | |
| 87081 | 31 | 27 | $127.70 | |
| 84703 | 19 | 15 | $116.61 | |
| 83540 | 43 | 40 | $94.75 | |
| 80047 | 14 | 12 | $82.38 | |
| 82947 | 17 | 17 | $57.71 | |
| 86592 | 28 | 25 | $54.79 | |
| 85610 | 37 | 28 | $40.64 | |
| A0425 | Ground mileage, per statute mile | 3,210 | 2,309 | $15.05 |
| 86850 | 12 | 12 | $5.05 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 473 | 409 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 182 | 139 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 57 | 51 | $0.00 |
| 93041 | 13 | 12 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 446 | 375 | $0.00 |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | 451 | 349 | $0.00 |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 466 | 392 | $0.00 |
| A9270 | Non-covered item or service | 180 | 139 | $0.00 |